TSRL Inc.

Highlights:


TSRL Awarded
Phase I SBIR Grant... more arrow

TSRL Awarded
Phase I SBIR Grant...more arrow

TSRL Awarded Phase II SBIR Grant... more arrow

TSRL Announces the Addition of Two Scientists... more arrow

Strategies in Oral Drug Delivery 2008... more arrow

BCS Classification System available online... more arrow

MB Software... more arrow

Therapeutic Systems Research Laboratories (TSRL), Inc. is a privately owned oral drug delivery specialty firm focused on R&D efforts to enhance the oral absorption of investigational and marketed compounds currently not suitable for this most convenient route of drug administration. We have developed a variety of patented technologies for improving oral absorption of drug candiates, including prodrug and carrier technologies as well as time and rate controlled delivery systems. Through customized problem-solving strategies and tailored delivery solutions, TSRL is able to provide patentable oral drug delivery technologies for drug candidates with low solubility, low intestinal permeability and those which are highly metabolized. Take a look at our Technology Solution examples.

Our preclinical services provide our partners with identification of the underlying mechanism of limited oral drug absorption, together with innovative strategies to overcome those limitations. Furthermore, we provide biopharmaceutics classifications (BCS) for drug candidates, a system accepted by the FDA for requesting clinical biowaivers for drug product manufacturing and post-approval changes.